SoftOx Solutions AS will hold its Annual General Meeting on 27th June 2025 at 10
am(CEST). The notice convening the General Meeting, including the agenda and the
board's proposals for the matters to be dealt with, is enclosed with this
notification and will be sent to all shareholders. Relevant documents referred
to in the notice are also made available at
https://soft-ox.com/stock-market-announcements/

For further information, please contact: 
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165 
Mail: ir@soft-ox.com  
 
About SoftOx Solutions AS: 
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
listed on Euronext Growth Oslo. The company is developing highly effective
pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The
technology is based on extensive research and development in partnership with
leading Nordic research institutes.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.